Research News Hubb
Advertisement Banner
  • Home
  • Global Trends
  • Market Research
  • Contact
No Result
View All Result
  • Home
  • Global Trends
  • Market Research
  • Contact
No Result
View All Result
Research News Hubb
No Result
View All Result
Home Global Trends

Diabetes Drug Metformin Identified as Potential Atrial Fibrillation Treatment, say Researchers

admin by admin
November 25, 2022
in Global Trends


In a new development, researchers at Cleveland Clinic have found metformin – a common diabetes drug, as a prospective treatment for atrial fibrillation.

The study appears in Cell Reports Medicine. The findings of the study is based on ongoing collaborative Cleveland Clinic initiative to support further examination into metformin as a drug repurposing prospect.

In order to establish this, researchers used genetic sequencing and advanced computation to find that metformin’s spectrum significantly overlap with unregulated genes in atrial fibrillation.

“In fact, to find drugs or procedures to treat atrial fibrillation is challenging because of potential side effects, stated senior author of the study.

There is a significant need for novel treatments for atrial fibrillation, with no new drugs been approved in more than a decade.

“Nonetheless, the drug found is not, where it takes 20 years to test it on individuals,” stated the first author of the study.

“With this finding, 10+ years can be cut in the drug development pipeline. The information is already there. It only requires to test in a computationally efficient way, such as AI technology,” stated the co-senior author of the study.

Meanwhile, analysis of the drug found metformin targeted 30 genes associated with atrial fibrillation, which directly affected eight for gene expression. During analysis, eight other drug alternatives surfaced, but researchers were able to find metformin as the most attractive candidate through examination and reviewing outcomes in large volume of patient data.

Importantly, the research is undertaken at the lab, which uses network medicine approach to find prospective drugs for repurposing, create vast networks of molecular interactions. For the study, researchers identified a list of 2,800 FDA-approved treatments by studying three sources: a network of genes related with atrial fibrillation, a map of interactions between proteins, and each medicine’s genetic or molecular targets.

Like this:

Like Loading…



Source link

Previous Post

Primary Data vs. Secondary Data: Market Research Methods

Next Post

Travel Purchase Journey: Connecting with consumers at every stage

Next Post

Travel Purchase Journey: Connecting with consumers at every stage

Recommended

Biosimilars Market Growth Driven by Increasing Development of Biologics

5 months ago

Southwest’s Crisis Is A Lesson For Innovators

4 weeks ago

World cuisine food products increasing their appeal

5 months ago

No, March Isn’t Toilet Paper And Pasta Month Buyer insight data

1 month ago

Small changes, big effects: how brands can deal with shrinkflation

1 day ago

Flexible Data Sharing Could Speed up Battery Advancement

2 months ago

© 2022 Research News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • Global Trends
  • Market Research
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • Global Trends
  • Market Research
  • Contact

© 2022 Research News Hubb All rights reserved.